By API User
BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the potential of BGB-B2033 in an area of high unmet need SAN CARLOS, Calif.–BUSINESS WIRE– BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the … Continued
By API User
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was … Continued
By API User
La Trobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more … Continued
By API User
Hepatitis Australia has today welcomed the Australian Government’s investment in viral hepatitis prevention, testing and treatment measures and community-led initiatives announced in the Mid-Year Economic and Fiscal Outlook (MYEFO). The national Hepatitis peak said that the additional funding comes at a critical moment in Australia’s push to eliminate hepatitis B and hepatitis C by 2030 … Continued
By API User
Dementia Australia is reminding Australians that dementia support and information is available 24 hours a day, seven days a week throughout the holiday period, which can be a challenging time for people living with dementia, their families and carers. The National Dementia Helpline 1800 100 500, will remain open for information and support across the … Continued
By API User
MEDIA RELEASE Thursday, 18 December 2025 ANZGOG welcomes three new Board Directors, expanding expertise and strengthening governance to advance gynaecological cancer research The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is pleased to announce the appointment of three new Board Directors: Beth Slatyer, Catherine Whitby GAICD and Grace Chu GAICD. They will join ANZGOG’s existing Board, comprising 12 esteemed leaders with deep … Continued
By API User
Monash University is working to address the critical shortage of general practice (GP) doctors in rural Australia, with the announcement of an enhanced training pathway allowing students to complete their training in Mildura. Enabled by a recent allocation of federal funding to train the next generation of rural GPs and Rural Generalists, the Monash Mildura … Continued
By API User
The Leukaemia Foundation is pleased to announce the appointment of Professor James Ward to its Board, effective immediately. Professor Ward brings a wealth of experience, a strong commitment to equity, and deep expertise in Indigenous health – qualities that will be invaluable as we intensify our efforts to support all Australians impacted by blood cancer. … Continued
By API User
The Leukaemia Foundation is delighted to announce the appointment of Professor John Seymour to its Board, effective immediately. With more than three decades of world-class leadership in haematology, research and patient care, Professor Seymour brings exceptional clinical and translational expertise to the Leukaemia Foundation Board – a major asset as we work to accelerate progress … Continued
By API User
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / December 17, 2025 / TruMerit, a worldwide leader in international credentials evaluation to support health worker careers, and the National Association of Pediatric Nurse Practitioners (NAPNAP), The Leader in Pediatric Education for Nurse Practitioners®, have announced they will jointly develop a global micro-credential to help advance the knowledge and … Continued
